Literature DB >> 29223926

An update on factor XI structure and function.

Bassem M Mohammed1, Anton Matafonov2, Ivan Ivanov2, Mao-Fu Sun2, Qiufang Cheng2, S Kent Dickeson2, Chan Li3, David Sun2, Ingrid M Verhamme2, Jonas Emsley3, David Gailani4.   

Abstract

Factor XI (FXI) is the zymogen of a plasma protease, factor XIa (FXIa), that contributes to thrombin generation during blood coagulation by proteolytic activation of several coagulation factors, most notably factor IX (FIX). FXI is a homolog of prekallikrein (PK), a component of the plasma kallikrein-kinin system. While sharing structural and functional features with PK, FXI has undergone adaptive changes that allow it to contribute to blood coagulation. Here we review current understanding of the biology and enzymology of FXI, with an emphasis on structural features of the protein as they relate to protease function.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Factor IX; Factor XI; Factor XIIa; Factor XIa; Prekallikrein

Mesh:

Substances:

Year:  2017        PMID: 29223926      PMCID: PMC5776729          DOI: 10.1016/j.thromres.2017.10.008

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  131 in total

1.  WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

Authors:  E W DAVIE; O D RATNOFF
Journal:  Science       Date:  1964-09-18       Impact factor: 47.728

2.  Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation.

Authors:  Dharmaraj Samuel; Hong Cheng; Paul W Riley; Adrian A Canutescu; Chandrasekaran Nagaswami; John W Weisel; Zimei Bu; Peter N Walsh; Heinrich Roder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-20       Impact factor: 11.205

3.  Effects of glycosaminoglycans on factor XI activation by thrombin.

Authors:  D Gailani; G J Broze
Journal:  Blood Coagul Fibrinolysis       Date:  1993-02       Impact factor: 1.276

4.  Polyphosphate accelerates factor V activation by factor XIa.

Authors:  Sharon H Choi; Stephanie A Smith; James H Morrissey
Journal:  Thromb Haemost       Date:  2014-10-23       Impact factor: 5.249

Review 5.  Step-by-step evolution of vertebrate blood coagulation.

Authors:  R F Doolittle
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2009-08-10

6.  Factor XI activation by meizothrombin: stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine.

Authors:  P A von dem Borne; L O Mosnier; G Tans; J C Meijers; B N Bouma
Journal:  Thromb Haemost       Date:  1997-08       Impact factor: 5.249

Review 7.  Structural and functional features of factor XI.

Authors:  D Gailani; S B Smith
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

8.  A comparison of murine and human factor XI.

Authors:  D Gailani; M F Sun; Y Sun
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

9.  Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.

Authors:  Stephen B Smith; Ingrid M Verhamme; Mao-fu Sun; Paul E Bock; David Gailani
Journal:  J Biol Chem       Date:  2008-01-11       Impact factor: 5.157

10.  Three residues at the interface of factor XI (FXI) monomers augment covalent dimerization of FXI.

Authors:  M Zucker; A Zivelin; M Landau; N Rosenberg; U Seligsohn
Journal:  J Thromb Haemost       Date:  2009-06       Impact factor: 5.824

View more
  38 in total

1.  The evolution of factor XI and the kallikrein-kinin system.

Authors:  Michał B Ponczek; Aleksandr Shamanaev; Alec LaPlace; S Kent Dickeson; Priyanka Srivastava; Mao-Fu Sun; Andras Gruber; Christian Kastrup; Jonas Emsley; David Gailani
Journal:  Blood Adv       Date:  2020-12-22

2.  Brazilian propolis (AF-08) inhibits collagen-induced platelet aggregation without affecting blood coagulation.

Authors:  Chihiro Sugita; Atsushi Yamashita; Shigetoshi Tsutsumi; Hisahiro Kai; Tohru Sonoda; Hiroki Yoshida; Ryuichi Yamamoto; Yujiro Asada; Masahiko Kurokawa
Journal:  J Nat Med       Date:  2021-05-04       Impact factor: 2.343

3.  Exosites expedite blood coagulation.

Authors:  Maria Luiza Vilela Oliva; Ingrid Dreveny; Jonas Emsley
Journal:  J Biol Chem       Date:  2020-11-06       Impact factor: 5.157

Review 4.  Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present).

Authors:  Rami A Al-Horani
Journal:  Expert Opin Ther Pat       Date:  2019-12-19       Impact factor: 6.674

5.  Factor XI contributes to myocardial ischemia-reperfusion injury in mice.

Authors:  Christina U Lorentz; Norah G Verbout; Zhiping Cao; Lijuan Liu; Monica T Hinds; Owen J T McCarty; Ivan Ivanov; Erik I Tucker; David Gailani; András Gruber
Journal:  Blood Adv       Date:  2018-01-23

6.  Factor XI and pulmonary infections.

Authors:  D Gailani; B M Mohammed; Q Cheng
Journal:  Haemophilia       Date:  2018-05-29       Impact factor: 4.287

7.  A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.

Authors:  Rami A Al-Horani; Elsamani I Abdelfadiel; Daniel K Afosah; Shravan Morla; Jyothi C Sistla; Bassem Mohammed; Erika J Martin; Masahiro Sakagami; Donald F Brophy; Umesh R Desai
Journal:  J Thromb Haemost       Date:  2019-09-10       Impact factor: 5.824

8.  The clinical management of factor XI deficiency in pregnant women.

Authors:  Allison P Wheeler; Celeste Hemingway; David Gailani
Journal:  Expert Rev Hematol       Date:  2020-06-12       Impact factor: 2.929

Review 9.  Plasma contact factors as therapeutic targets.

Authors:  Benjamin F Tillman; Andras Gruber; Owen J T McCarty; David Gailani
Journal:  Blood Rev       Date:  2018-04-12       Impact factor: 8.250

10.  Factor XI promotes hemostasis in factor IX-deficient mice.

Authors:  B M Mohammed; Q Cheng; A Matafonov; D M Monroe; J C M Meijers; D Gailani
Journal:  J Thromb Haemost       Date:  2018-08-16       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.